Efficacy and tolerability of vildagliptin-based versus comparative dual therapy in type 2 diabetes
Crossref DOI link: https://doi.org/10.1007/s00508-014-0646-x
Published Online: 2015-01-10
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brath, Helmut
Bialek, Christoph
Gingl, Ewald
Resl, Michael
Prager, Rudolf
Ratzinger, Michaela
Text and Data Mining valid from 2015-01-10